Dihydropyridine calcium channel blocker tablets for antianginal and antihypertensive use in cardiovascular therapy. Manufactured by pharmaceutical companies for procurement by cardiologists via wholesalers, hospitals, and retail pharmacies in clinical and institutional environments.